Alzheimer's disease (AD) is a type of neurodegenerative disease that describes cognitive
decline and memory loss resulting in disability in movement, memory, speech etc. Which first …

Chitosan nanoparticles have emerged as a promising therapeutic platform for treating
neurological disorders due to their biocompatibility, biodegradability, and ease of …

Central nervous system diseases negatively affect patients and society. Providing successful
noninvasive treatments for these diseases is challenging because of the presence of the …

Modern nanotechnologies provide various possibilities for efficiently delivering drugs to
biological targets. This review focuses on using functionalized gold nanoparticles (GNPs) as …

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders that
leads to dementia among elderly. Formation of senile plaques in the brain by amyloid-β …

Numerous studies are focused on nanoparticle penetration into the brain functionalizing
them with ligands useful to cross the blood–brain barrier. However, cell targeting is also …

Nasal administration can bypass the blood‐brain barrier and directly deliver drugs to the
brain, providing a non‐invasive route for central nervous system (CNS) diseases. Inspired …

The transdermal delivery system was developed to overcome the side effect derived from
oral administration of tacrolimus in the treatment of atopic dermatitis (AD). The nanoparticles …

Alzheimer's disease (AD) represents an escalating global health crisis, constituting the
leading cause of dementia among the elderly and profoundly impairing their quality of life …

Increased intracellular Ca 2+ accumulation plays a pivotal role in the development and
progression of Alzheimer's disease (AD). Thus, utilization of calcium channel blockers …